TNF and psoriasis: This phenomenon known as “paradoxical psoriasis,” with IFX being the most commonly reported agent.[2,7,8] Although the mechanism of action tied to the development of psoriatic lesions has yet to be fully elucidated, there are several well-supported theories on the mechanism by which TNF-α inhibitors result in psoriatic lesion development.